Pulse Biosciences, Inc. , developer of the novel nPulsetm technology using its proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced first patient ...
To address this need, HMP Global today announced the launch of the Radiopharmaceutical Education Institute (RPEI), a new clinician-focused educational platform from Oncology Learning Network (OLN), ...
CMS is pursuing empiric fee-schedule accuracy in original Medicare (eg, validating procedure time assumptions) while rapidly expanding MSSP and CMMI pathways to move beyond unmanaged fee-for-service.
SILVER SPRING, Md. (AP) — SILVER SPRING, Md. (AP) — Urban One Inc. (UONEK) on Thursday reported a loss of $54.4 million in ...
HAYWARD, Calif., March 12, 2026--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond ...
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of the PREDICT-DNA study in the Journal of Clinical Oncology. The article, "The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results